Genlabs Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 24-06-2024
- Paid Up Capital ₹ 1.11 Cr
as on 24-06-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue -51.95%
(FY 2021)
- Profit -5.87%
(FY 2021)
- Ebitda 19.86%
(FY 2021)
- Net Worth -15.49%
(FY 2021)
- Total Assets -3.33%
(FY 2021)
About Genlabs Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.11 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suresh Srinivasan, Raju Ramesh, Narayan Srinivas, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100KA2013PTC071790
- Company No.
071790
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Genlabs Healthcare Private Limited offer?
Genlabs Healthcare Private Limited offers a wide range of products and services, including Medical Equipment & Accessories, Emergency Medical Equipment.
Who are the key members and board of directors at Genlabs Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Srinivasan  | Director | 09-Sep-2015 | Current |
| Raju Ramesh | Director | 11-Nov-2013 | Current |
| Narayan Srinivas | Director | 11-Nov-2013 | Current |
| Anand Sudarshan | Additional Director | 01-Jun-2019 | Current |
Financial Performance and Corporate Structure Insights of Genlabs Healthcare.
Genlabs Healthcare Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 51.95% decrease. The company also saw a slight decrease in profitability, with a 5.87% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genlabs Healthcare?
In 2021, Genlabs Healthcare had a promoter holding of 84.56% and a public holding of 15.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genlabs Healthcare?
Unlock and access historical data on people associated with Genlabs Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genlabs Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genlabs Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
